LUCERNE, Switzerland: GC Holding has recently announced the appointment of Dr Per Falk as CEO of the company, effective from 1 October. In April, GC Holding was set up as the parent company of the GC Group and the major shareholder in order to strengthen GC corporate governance. This decision builds on GC’s proud history as an agile organisation, founded in 1921 in Japan and run by the Nakao family for over 100 years.
In 1934, Kiyoshi Nakao first transitioned the GC Chemical Research Laboratory organisation into a corporate structure to support business transformation and ensure future growth. GC continued to develop into a global company under the leadership of its president at the time, Toshio Nakao. The company broke new ground with its famous Fuji brand of glass ionomer, launched in 1977, under the leadership of Makoto Nakao, who had been appointed executive director that year and was named president in 1983. On 1 October, Ayako Nakao became a member of GC Holding’s board of directors, continuing the Nakao family’s century-old entrepreneurial spirit.
Dr Falk’s appointment comes at a pivotal time, as GC is celebrating its 103rd anniversary and looking ahead to the next century of innovation and growth. He has been a member of GC’s board of directors for two and a half years. His career spans 25 years in the pharmaceutical industry, and he has joined GC from Ferring Pharmaceuticals, where he was president.
Makoto Nakao, chairman of the board of GC Holding, expressed his confidence in Dr Falk’s leadership: “It is very fortunate for the GC Group and its shareholders that Dr Falk will take on the CEO responsibility. His professional experience and knowledge of GC business, combined with the trust of the Nakao family, place him in an ideal position to become CEO of the GC Group.”
Commenting on his appointment, Dr Falk said: “I am very excited over the opportunity to lead GC in its next growth phase and am truly honoured by the trust and confidence given to me with this appointment. I look forward to working closely with our chairman, Mr Nakao, and all our skilled and dedicated colleagues to grow GC’s position as a strong contributor in the global dental and oral health sector.”
Under the leadership of GC Holding, headquartered in Lucerne, and its board of directors, GC is focused on its future to further develop its legacy of excellence in dental care, create value for stakeholders and improve oral health.
More information about the company can be found here.
Tags:
GENEVA, Switzerland: Last week, GC International held the Symposium on Innovation in Biomaterials for Periodontal Regeneration as part of the CED/NOF-IADR ...
SÃO PAULO, Brazil: GC South America is pleased to announce its participation at the 41st São Paulo International Dental Congress (CIOSP), scheduled to ...
COLOGNE, Germany: Continually striving for digitalisation in dental settings, GC announced the launch of two new solutions during the recent 40th ...
SÃO PAULO, Brazil: The 40th São Paulo International Dental Congress (CIOSP), one of the world’s largest dentistry events, took place from 25 to 28 ...
SÃO PAULO, Brazil: After three years of social distancing, PRO EXPERIENCE, the Congresso Internacional de Prótese Odontológica (international dental ...
SIENA, Italy: From 22 to 24 September, the annual European Prosthodontic Association (EPA) Conference took place in Siena under the presidency of Prof. ...
Live webinar
Tue. 16 September 2025
8:00 pm EST (New York)
Live webinar
Wed. 15 October 2025
7:00 pm EST (New York)
Dr. Julie Driscoll DMD, FAGD
Live webinar
Mon. 27 October 2025
2:00 pm EST (New York)
Dr. Kostas Karagiannopoulos, MDT Stefan M. Roozen MDT
Live webinar
Fri. 14 November 2025
7:00 pm EST (New York)
Dr. Poonam Jain BDS, MS, MPH
Dr. Antonino G. Secchi DMD, MS
Prof. Roland Frankenberger Univ.-Prof. Dr. med. dent. Prof. h.c. FICD FADM FPFA, Georg Benjamin
Dr. David Gerdolle DMD, MS
To post a reply please login or register